Loading...
Not a good buy right now. TWLO is in a short-term downtrend (bearish MACD expansion, trading below the pivot at 126.64) with price sitting just above key support (118.41). While options positioning is mildly bullish (put/call ratios < 1) and RSI is near oversold (potential bounce), there is no Intellectia buy signal today and the stock lacks a near-term positive catalyst (no news; next major event is earnings on 2026-02-12). For an impatient buyer, the risk of further downside toward support outweighs the immediate upside setup.
Trend/structure is bearish near-term. MACD histogram is negative (-0.349) and worsening (bearish momentum building). RSI(6) at ~32 is near oversold, which can precede a reflex bounce, but it is not a confirmed reversal signal. Price is below the pivot resistance (126.638), implying rallies may face selling pressure; key levels: support S1 118.414 then S2 113.332, resistance R1 134.862. Converging moving averages suggest consolidation after weakness rather than a clean uptrend resumption. Net: more downside risk than upside clarity at current ~120.

Potential technical bounce risk due to near-oversold RSI and proximity to support (~118). Options positioning is call-tilted (P/C ratios below 1). Analyst commentary highlights AI/Voice tailwinds and platform integration as potential 2026 growth drivers. Upcoming QDEC 2025 earnings (2026-02-12 after hours) could be a catalyst if guidance/FCF surprises positively.
Momentum is currently bearish (MACD negative and expanding) and price is below the pivot (126.64), increasing odds of a drift/test toward 118.41 and possibly 113.33 if support fails. No supportive news flow in the past week. Earnings is a binary event and, without a clear uptrend or buy signal, an impatient entry ahead of results carries poor timing. Trading trends show no supportive accumulation signal (hedge funds/insiders neutral; no congress trading data).
Latest reported quarter: 2025/Q3. Revenue grew to ~$1.300B (+14.71% YoY), showing top-line re-acceleration. However, profitability deteriorated sharply: net income fell to ~$37.2M (-482.97% YoY) and EPS to $0.23 (-483.33% YoY), alongside gross margin decline to 48.61% (-4.76% YoY). The growth is real, but margin/earnings trend is currently the key weakness.
Recent analyst trend is mixed but skewed to higher price targets: Oppenheimer raised PT to $170 (Outperform), Citizens raised to $185 (Outperform), BTIG initiated Buy with $165, and Baird reiterated Outperform with PT $145. Offsetting this, Piper Sandler downgraded to Neutral (PT $148) citing valuation and limited further upside to FCF revisions, and RBC raised PT to $100 but kept Underperform. Wall Street pros: AI/Voice tailwinds, category leadership, improving enterprise demand. Cons: valuation less compelling after run, potential narrative fade later in 2026, and recent profitability/margin pressure.